81 related articles for article (PubMed ID: 21476898)
1. Multiallelic synthetic quality control material: lessons learned from the cystic fibrosis external quality assessment scheme.
Berwouts S; Christensen TM; Brandon J; Bejjani BA; Barton DE; Dequeker E
Genet Test Mol Biomarkers; 2011 Sep; 15(9):579-86. PubMed ID: 21476898
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and use of a synthetic quality control material, included in the European external quality assessment scheme for cystic fibrosis.
Berwouts S; Gordon JT; Rundell CA; Barton DE; Dequeker E
Hum Mutat; 2008 Aug; 29(8):1063-70. PubMed ID: 18470946
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing and quality control in diagnostic laboratories.
Dequeker E; Cassiman JJ
Nat Genet; 2000 Jul; 25(3):259-60. PubMed ID: 10888869
[TBL] [Abstract][Full Text] [Related]
4. Mutation nomenclature in practice: findings and recommendations from the cystic fibrosis external quality assessment scheme.
Berwouts S; Morris MA; Girodon E; Schwarz M; Stuhrmann M; Dequeker E
Hum Mutat; 2011 Nov; 32(11):1197-203. PubMed ID: 21796730
[TBL] [Abstract][Full Text] [Related]
5. The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis: 4 years of activity.
Salvatore M; Falbo V; Floridia G; Censi F; Tosto F; Bombieri C; Castaldo G; Pignatti PF; Rosatelli MC; Taruscio D
Clin Chem Lab Med; 2007; 45(2):254-60. PubMed ID: 17311518
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of CFTR gene mutation testing methods in 136 diagnostic laboratories: report of a large European external quality assessment.
Dequeker E; Cassiman JJ
Eur J Hum Genet; 1998; 6(2):165-75. PubMed ID: 9781062
[TBL] [Abstract][Full Text] [Related]
7. Introduction to PCR/OLA/SCS, a multiplex DNA test, and its application to cystic fibrosis.
Brinson EC; Adriano T; Bloch W; Brown CL; Chang CC; Chen J; Eggerding FA; Grossman PD; Iovannisci DM; Madonik AM; Sherman DG; Tam RW; Winn-Deen ES; Woo SL; Fung S
Genet Test; 1997; 1(1):61-8. PubMed ID: 10464627
[TBL] [Abstract][Full Text] [Related]
8. Detection of large rearrangements in the cystic fibrosis transmembrane conductance regulator gene by multiplex ligation-dependent probe amplification assay when sequencing fails to detect two disease-causing mutations.
Svensson AM; Chou LS; Miller CE; Robles JA; Swensen JJ; Voelkerding KV; Mao R; Lyon E
Genet Test Mol Biomarkers; 2010 Apr; 14(2):171-4. PubMed ID: 20059381
[TBL] [Abstract][Full Text] [Related]
9. Introduction to molecular cystic fibrosis testing.
Uphoff TS; Highsmith WE
Clin Lab Sci; 2006; 19(1):24-31. PubMed ID: 16617555
[TBL] [Abstract][Full Text] [Related]
10. Validation for clinical use of, and initial clinical experience with, a novel approach to population-based carrier screening using high-throughput, next-generation DNA sequencing.
Hallam S; Nelson H; Greger V; Perreault-Micale C; Davie J; Faulkner N; Neitzel D; Casey K; Umbarger MA; Chennagiri N; Kramer AC; Porreca GJ; Kennedy CJ
J Mol Diagn; 2014 Mar; 16(2):180-9. PubMed ID: 24374108
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence-based oligonucleotide ligation assay for analysis of cystic fibrosis transmembrane conductance regulator gene mutations.
Eggerding FA; Iovannisci DM; Brinson E; Grossman P; Winn-Deen ES
Hum Mutat; 1995; 5(2):153-65. PubMed ID: 7538376
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic testing for cystic fibrosis: laboratory performance on the College of American Pathologists external proficiency surveys.
Lyon E; Schrijver I; Weck KE; Ferreira-Gonzalez A; Richards CS; Palomaki GE;
Genet Med; 2015 Mar; 17(3):219-25. PubMed ID: 25077647
[TBL] [Abstract][Full Text] [Related]
13. Next generation diagnostics of cystic fibrosis and CFTR-related disorders by targeted multiplex high-coverage resequencing of CFTR.
Trujillano D; Ramos MD; González J; Tornador C; Sotillo F; Escaramis G; Ossowski S; Armengol L; Casals T; Estivill X
J Med Genet; 2013 Jul; 50(7):455-62. PubMed ID: 23687349
[TBL] [Abstract][Full Text] [Related]
14. Long-range (17.7 kb) allele-specific polymerase chain reaction method for direct haplotyping of R117H and IVS-8 mutations of the cystic fibrosis transmembrane regulator gene.
Pont-Kingdon G; Jama M; Miller C; Millson A; Lyon E
J Mol Diagn; 2004 Aug; 6(3):264-70. PubMed ID: 15269305
[TBL] [Abstract][Full Text] [Related]
15. Variability in the use of CE-marked assays for in vitro diagnostics of CFTR gene mutations in European genetic testing laboratories.
Camajova J; Berwouts S; Matthijs G; Macek M; Dequeker E
Eur J Hum Genet; 2009 Apr; 17(4):537-40. PubMed ID: 19050730
[TBL] [Abstract][Full Text] [Related]
16. One multiplex control for 29 cystic fibrosis mutations.
Lebo RV; Bixler M; Galehouse D
Genet Test; 2007; 11(3):256-68. PubMed ID: 17949287
[TBL] [Abstract][Full Text] [Related]
17. Development of genomic reference materials for cystic fibrosis genetic testing.
Pratt VM; Caggana M; Bridges C; Buller AM; DiAntonio L; Highsmith WE; Holtegaard LM; Muralidharan K; Rohlfs EM; Tarleton J; Toji L; Barker SD; Kalman LV
J Mol Diagn; 2009 May; 11(3):186-93. PubMed ID: 19359498
[TBL] [Abstract][Full Text] [Related]
18. Verification of performance specifications of a molecular test: cystic fibrosis carrier testing using the Luminex liquid bead array.
Lacbawan FL; Weck KE; Kant JA; Feldman GL; Schrijver I;
Arch Pathol Lab Med; 2012 Jan; 136(1):14-9. PubMed ID: 22208482
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population.
Castaldo G; Polizzi A; Tomaiuolo R; Cazeneuve C; Girodon E; Santostasi T; Salvatore D; Raia V; Rigillo N; Goossens M; Salvatore F
Ann Hum Genet; 2005 Jan; 69(Pt 1):15-24. PubMed ID: 15638824
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between phenotype and genotype in a group of patients with cystic fibrosis].
Navarro H; Kolbach M; Repetto G; Guiraldes E; Harris P; Foradori A; Poggi H; Sánchez I
Rev Med Chil; 2002 May; 130(5):475-81. PubMed ID: 12143267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
